Watts Ryan J.

EDGAR CIK 0001724310

Denali Therapeutics Inc. - DNLI

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CEO Director
President and CEO
Direct Buys
0
$0
0 Shares
Direct Sells
2
($219,559)
-11,849 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
2
($494,335)
-25,301 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
08/20/2024
08/22/2024
Sell
-2,260 @ $23.79
 ($53,765) 235,807 (-0.95%) Direct
02/13/2024
02/15/2024
Sell
-9,589 @ $17.29
 ($165,794) 238,067 (-3.87%) Direct
01/09/2024
01/11/2024
Sell
-7,818 @ $19.78
 ($154,640) 2,268,363 (-0.34%) Indirect - See footnote
01/05/2024
01/09/2024
Sell
-17,483 @ $19.43
 ($339,695) 2,276,181 (-0.76%) Indirect - See footnote